Tony Yao's most recent trade in 4D Molecular Therapeutics Inc was a trade of 455,326 Series B Preferred Stock done . Disclosure was reported to the exchange on Dec. 15, 2020.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
4D Molecular Therapeutics Inc | Tony Yao | Director | 15 Dec 2020 | 455,326 | 0 | - | - | Series B Preferred Stock | ||
4D Molecular Therapeutics Inc | Tony Yao | Director | 15 Dec 2020 | 455,326 | 455,326 | - | - | Common Stock | ||
4D Molecular Therapeutics Inc | Tony Yao | Director | Purchase of securities on an exchange or from another person at price $ 23.00 per share. | 15 Dec 2020 | 425,000 | 1,060,880 | - | 23 | 9,775,000 | Common Stock |
4D Molecular Therapeutics Inc | Tony Yao | Director | 15 Dec 2020 | 180,554 | 0 | - | - | Series C Preferred Stock | ||
4D Molecular Therapeutics Inc | Tony Yao | Director | 15 Dec 2020 | 180,554 | 635,880 | - | - | Common Stock | ||
4D Molecular Therapeutics Inc | Tony Yao | Director | 15 Dec 2020 | 2,864 | 0 | - | - | Series B Preferred Stock | ||
4D Molecular Therapeutics Inc | Tony Yao | Director | 15 Dec 2020 | 2,864 | 2,864 | - | - | Common Stock |